Vernon L. Alvarez
-
- Radiopharmaceutical Chemistry and Applications 11
- Monoclonal and Polyclonal Antibodies Research 7
-
- Glioma Diagnosis and Treatment 4
- Blood disorders and treatments 2
-
- Cell Adhesion Molecules Research 3
-
- Glycosylation and Glycoproteins Research 5
-
- Protease and Inhibitor Mechanisms 4
-
- Neuroblastoma Research and Treatments 2
Vernon L. Alvarez
23 papers receiving 553 citations
Peers
Comparison fields: 5 of 87
- Radiology, Nuclear Medicine and Imaging 275
- Genetics 61
- Immunology and Allergy 29
- Molecular Biology 265
- Oncology 105
Countries citing papers authored by Vernon L. Alvarez
This map shows the geographic impact of Vernon L. Alvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vernon L. Alvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vernon L. Alvarez more than expected).
Fields of papers citing papers by Vernon L. Alvarez
This network shows the impact of papers produced by Vernon L. Alvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vernon L. Alvarez. The network helps show where Vernon L. Alvarez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vernon L. Alvarez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 173 | |
| 2 | 2005 | 45 | |
| 3 | 2005 | 2 | |
| 4 | 2004 | 2 | |
| 5 | 2004 | 2 | |
| 6 | 2003 | 2 | |
| 7 | Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets. | 1994 | 28 |
| 8 | Radioimmunotherapy of peritoneal human colon cancer xenografts with site-specifically modified 212Bi-labeled antibody. | 1990 | 16 |
| 9 | Site-specifically radioiodinated antibody for targeting tumors. | 1990 | 4 |
| 10 | Radioimmunoscintigraphy and radioimmunotherapy in nude mouse models. Studies with site-specifically modified monoclonal antibodies. | 1989 | 2 |
| 11 | Radioimmunoscintigraphy and radioimmunotherapy of renal cell carcinoma xenografts. | 1987 | 15 |
| 12 | 1986 | 16 | |
| 13 | 1986 | 189 | |
| 14 | 1984 | 2 | |
| 15 | 1980 | 4 | |
| 16 | 1977 | 32 | |
| 17 | 1977 | 18 | |
| 18 | 1977 | 6 | |
| 19 | 1977 | 1 | |
| 20 | 1976 | 24 |
About Vernon L. Alvarez
Vernon L. Alvarez is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Genetics, having authored 23 papers that have together received 593 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (5 papers), Glioma Diagnosis and Treatment (4 papers), Protease and Inhibitor Mechanisms (4 papers), Cell Adhesion Molecules Research (3 papers), Neuroblastoma Research and Treatments (2 papers) and Blood disorders and treatments (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (275 citations), Genetics (61 citations) and Immunology and Allergy (29 citations). Vernon L. Alvarez has collaborated with scholars based in United States and Switzerland. Frequent co-authors include John D. Rodwell, Thomas J. McKearn, Dalton King, M.B. Khazaeli, John Goers, Sui Shen, L.B. Sandberg, Matthew A. Gonda, G. Yancey Gillespie and Richard D. Bucholz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.